North Star Investment Management Corp. Biomarin Pharmaceutical Inc Transaction History

North Star Investment Management Corp.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 16, 2020	SELL	$79.55 - $124.22 $29,115 - $45,464	-366 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$64.27 - $86.37 $64 - $86	-1 Reduced 0.27%	366 $31,000
Q3 2019 Oct 03, 2019	BUY	$67.4 - $85.11 $24,735 - $31,235	367 New	367 $25,000
Q2 2019 Jul 15, 2019	SELL	$80.35 - $93.9 $29,488 - $34,461	-367 Closed	0 $0
Q4 2018 Jan 07, 2019	BUY	$80.14 - $106.07 $80 - $106	1 Added 0.27%	367 $31,000
Q1 2018 Apr 13, 2018	BUY	$77.67 - $92.63 $28,427 - $33,902	366 New	366 $30,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

Stay updated on North Star Investment Management Corp. with notifications on news.